Top

Tumor Biology

Published in:

Open Access 01-03-2015 | Research Article

Lymphovascular invasion and histologic grade are associated with specific genomic profiles in invasive carcinomas of the breast

Published in: Tumor Biology | Issue 3/2015

Title: Lymphovascular invasion and histologic grade are associated with specific genomic profiles in invasive carcinomas of the breast
Publication date: 01-03-2015
Published in: Tumor Biology / Issue 3/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-014-2786-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/2015

Activating transcription factor 3 interferes with p21 activation in histone deacetylase inhibitor-induced growth inhibition of epidermoid carcinoma cells

A Huaier polysaccharide inhibits hepatocellular carcinoma growth and metastasis

Comment on Zong et al.: “Reproductive factors in relation to risk of brain tumors in women: an updated meta-analysis of 27 independent studies”

Overexpression of SMARCA5 correlates with cell proliferation and migration in breast cancer

Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts

Matrine inhibits the growth and induces apoptosis of osteosarcoma cells in vitro by inactivating the Akt pathway

Keynote webinar | Spotlight on antibody–drug conjugates in cancer